GeneThera, Inc. filed its 10-K on Apr 14, 2022 for the period ending Dec 31, 2021. In this report its auditor, MaughanSullivan LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.98% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 35 | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- GTHR Stock
- News GeneThera, Inc.
- GeneThera, Inc. Auditor Raises 'Going Concern' Doubt